// App-Quantinova.ai

932 : The UP study – Ursodeoxycholic acid (UDCA) as neuroprotective treatment for Parkinson’s disease

Researchers

Presenter

  • T. Payne

Principal Investigators

  • M. Appleby

  • E. Buckley

  • C. Mazza

  • T. Foltynie

  • O. Bandmann

Medical Centers

  • N/A

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Parkinson's disease

Biomarkers

  • MDS-Unified Parkinson's Disease Rating Scale

Drug/Treatment

  • Ursodeoxycholic acid

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Controlled

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved